ID   SUOX_HUMAN              Reviewed;         545 AA.
AC   P51687;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 2.
DT   10-MAY-2017, entry version 181.
DE   RecName: Full=Sulfite oxidase, mitochondrial;
DE            EC=1.8.3.1;
DE   Flags: Precursor;
GN   Name=SUOX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=7599189; DOI=10.1016/0167-4781(95)00068-R;
RA   Garrett R.M., Bellissimo D.B., Rajagopalan K.V.;
RT   "Molecular cloning of human liver sulfite oxidase.";
RL   Biochim. Biophys. Acta 1262:147-149(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 18-545.
RA   Coyne K.E., Johnson J.L., Rajagopalan K.V.;
RT   "Genomic DNA sequence of human sulfite oxidase SUOX.";
RL   Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-123, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 79-160 IN COMPLEX WITH HEME,
RP   AND COFACTOR.
RX   PubMed=12832761; DOI=10.1107/S0907444903009934;
RA   Rudolph M.J., Johnson J.L., Rajagopalan K.V., Kisker C.;
RT   "The 1.2 A structure of the human sulfite oxidase cytochrome b(5)
RT   domain.";
RL   Acta Crystallogr. D 59:1183-1191(2003).
RN   [6]
RP   VARIANTS ISOD GLN-217; ASP-265; TYR-427 AND ASP-530.
RX   PubMed=9428520; DOI=10.1016/S0092-8674(00)80488-2;
RA   Kisker C., Schindelin H., Pacheco A., Wehbi W.A., Garrett R.M.,
RA   Rajagopalan K.V., Enemark J.H., Rees D.C.;
RT   "Molecular basis of sulfite oxidase deficiency from the structure of
RT   sulfite oxidase.";
RL   Cell 91:973-983(1997).
RN   [7]
RP   VARIANT ISOD GLN-217.
RX   PubMed=9600976; DOI=10.1073/pnas.95.11.6394;
RA   Garrett R.M., Johnson J.L., Graf T.N., Feigenbaum A.,
RA   Rajagopalan K.V.;
RT   "Human sulfite oxidase R160Q: identification of the mutation in a
RT   sulfite oxidase-deficient patient and expression and characterization
RT   of the mutant enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:6394-6398(1998).
RN   [8]
RP   VARIANTS ISOD ASP-265 AND TYR-427.
RX   PubMed=10519592; DOI=10.1016/S0161-6420(99)90408-6;
RA   Edwards M.C., Johnson J.L., Marriage B., Graf T.N., Coyne K.E.,
RA   Rajagopalan K.V., MacDonald I.M.;
RT   "Isolated sulfite oxidase deficiency: review of two cases in one
RT   family.";
RL   Ophthalmology 106:1957-1961(1999).
RN   [9]
RP   VARIANTS ISOD LEU-258; GLN-268; SER-362; HIS-366; ARG-379; ARG-396 AND
RP   ARG-450.
RX   PubMed=12112661; DOI=10.1002/humu.9038;
RA   Johnson J.L., Coyne K.E., Garrett R.M., Zabot M.-T., Dorche C.,
RA   Kisker C., Rajagopalan K.V.;
RT   "Isolated sulfite oxidase deficiency: identification of 12 novel SUOX
RT   mutations in 10 patients.";
RL   Hum. Mutat. 20:74-74(2002).
RN   [10]
RP   VARIANT ISOD GLN-217.
RX   PubMed=12368985; DOI=10.1055/s-2002-34491;
RA   Lee H.F., Mak B.S., Chi C.S., Tsai C.R., Chen C.H., Shu S.G.;
RT   "A novel mutation in neonatal isolated sulphite oxidase deficiency.";
RL   Neuropediatrics 33:174-179(2002).
CC   -!- CATALYTIC ACTIVITY: Sulfite + O(2) + H(2)O = sulfate + H(2)O(2).
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344;
CC         Evidence={ECO:0000269|PubMed:12832761};
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group non-
CC       covalently per subunit. {ECO:0000269|PubMed:12832761};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000250};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000250};
CC   -!- PATHWAY: Energy metabolism; sulfur metabolism.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P37198:NUP62; NbExp=5; IntAct=EBI-3921347, EBI-347978;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space.
CC   -!- DISEASE: Isolated sulfite oxidase deficiency (ISOD) [MIM:272300]:
CC       Characterized by neurological abnormalities including multicystic
CC       leukoencephalopathy with brain atrophy. Patients often suffer from
CC       seizures. Often leads to death at an early age.
CC       {ECO:0000269|PubMed:10519592, ECO:0000269|PubMed:12112661,
CC       ECO:0000269|PubMed:12368985, ECO:0000269|PubMed:9428520,
CC       ECO:0000269|PubMed:9600976}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA74886.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAL08048.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L31573; AAA74886.1; ALT_INIT; mRNA.
DR   EMBL; BC065193; AAH65193.2; -; mRNA.
DR   EMBL; AY056018; AAL08048.1; ALT_INIT; Genomic_DNA.
DR   CCDS; CCDS8901.2; -.
DR   PIR; S55874; S55874.
DR   RefSeq; NP_000447.2; NM_000456.2.
DR   RefSeq; NP_001027558.1; NM_001032386.1.
DR   RefSeq; NP_001027559.1; NM_001032387.1.
DR   RefSeq; XP_016875396.1; XM_017019907.1.
DR   RefSeq; XP_016875397.1; XM_017019908.1.
DR   UniGene; Hs.558403; -.
DR   PDB; 1MJ4; X-ray; 1.20 A; A=79-160.
DR   PDBsum; 1MJ4; -.
DR   ProteinModelPortal; P51687; -.
DR   SMR; P51687; -.
DR   BioGrid; 112690; 8.
DR   IntAct; P51687; 47.
DR   STRING; 9606.ENSP00000266971; -.
DR   iPTMnet; P51687; -.
DR   PhosphoSitePlus; P51687; -.
DR   BioMuta; SUOX; -.
DR   DMDM; 152031695; -.
DR   EPD; P51687; -.
DR   MaxQB; P51687; -.
DR   PaxDb; P51687; -.
DR   PeptideAtlas; P51687; -.
DR   PRIDE; P51687; -.
DR   Ensembl; ENST00000266971; ENSP00000266971; ENSG00000139531.
DR   Ensembl; ENST00000356124; ENSP00000348440; ENSG00000139531.
DR   Ensembl; ENST00000394109; ENSP00000377668; ENSG00000139531.
DR   Ensembl; ENST00000394115; ENSP00000377674; ENSG00000139531.
DR   Ensembl; ENST00000548274; ENSP00000450245; ENSG00000139531.
DR   Ensembl; ENST00000550065; ENSP00000450264; ENSG00000139531.
DR   GeneID; 6821; -.
DR   KEGG; hsa:6821; -.
DR   UCSC; uc001six.4; human.
DR   CTD; 6821; -.
DR   DisGeNET; 6821; -.
DR   GeneCards; SUOX; -.
DR   HGNC; HGNC:11460; SUOX.
DR   HPA; HPA038208; -.
DR   HPA; HPA038209; -.
DR   MalaCards; SUOX; -.
DR   MIM; 272300; phenotype.
DR   MIM; 606887; gene.
DR   neXtProt; NX_P51687; -.
DR   OpenTargets; ENSG00000139531; -.
DR   Orphanet; 99731; Isolated sulfite oxidase deficiency.
DR   PharmGKB; PA36250; -.
DR   eggNOG; KOG0535; Eukaryota.
DR   eggNOG; KOG4576; Eukaryota.
DR   eggNOG; COG2041; LUCA.
DR   GeneTree; ENSGT00390000003749; -.
DR   HOGENOM; HOG000252609; -.
DR   HOVERGEN; HBG017865; -.
DR   InParanoid; P51687; -.
DR   KO; K00387; -.
DR   OMA; AVHNQSH; -.
DR   OrthoDB; EOG091G0DBF; -.
DR   PhylomeDB; P51687; -.
DR   TreeFam; TF300905; -.
DR   BioCyc; MetaCyc:HS06627-MONOMER; -.
DR   BRENDA; 1.8.3.1; 2681.
DR   Reactome; R-HSA-1614517; Sulfide oxidation to sulfate.
DR   SABIO-RK; P51687; -.
DR   UniPathway; UPA00096; -.
DR   ChiTaRS; SUOX; human.
DR   EvolutionaryTrace; P51687; -.
DR   GeneWiki; Sulfite_oxidase; -.
DR   GenomeRNAi; 6821; -.
DR   PRO; PR:P51687; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139531; -.
DR   CleanEx; HS_SUOX; -.
DR   ExpressionAtlas; P51687; baseline and differential.
DR   Genevisible; P51687; HS.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0030151; F:molybdenum ion binding; IEA:InterPro.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; IEA:InterPro.
DR   GO; GO:0008482; F:sulfite oxidase activity; TAS:Reactome.
DR   GO; GO:0042128; P:nitrate assimilation; IEA:InterPro.
DR   GO; GO:0070221; P:sulfide oxidation, using sulfide:quinone oxidoreductase; TAS:Reactome.
DR   Gene3D; 3.10.120.10; -; 1.
DR   Gene3D; 3.90.420.10; -; 1.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR018506; Cyt_B5_heme-BS.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR005066; MoCF_OxRdtse_dimer.
DR   InterPro; IPR008335; Mopterin_OxRdtase_euk.
DR   InterPro; IPR000572; OxRdtase_Mopterin-bd_dom.
DR   InterPro; IPR022407; OxRdtase_Mopterin_BS.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   Pfam; PF03404; Mo-co_dimer; 1.
DR   Pfam; PF00174; Oxidored_molyb; 1.
DR   PRINTS; PR00363; CYTOCHROMEB5.
DR   PRINTS; PR00407; EUMOPTERIN.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; SSF55856; 1.
DR   SUPFAM; SSF56524; SSF56524; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS00191; CYTOCHROME_B5_1; 1.
DR   PROSITE; PS50255; CYTOCHROME_B5_2; 1.
DR   PROSITE; PS00559; MOLYBDOPTERIN_EUK; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disease mutation; Heme; Iron;
KW   Metal-binding; Mitochondrion; Molybdenum; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; Transit peptide.
FT   TRANSIT       1     79       Mitochondrion. {ECO:0000250}.
FT   CHAIN        80    545       Sulfite oxidase, mitochondrial.
FT                                /FTId=PRO_0000006481.
FT   DOMAIN       82    161       Cytochrome b5 heme-binding.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00279}.
FT   REGION      165    174       Hinge. {ECO:0000250}.
FT   REGION      175    401       Moco domain. {ECO:0000250}.
FT   REGION      215    219       Molybdopterin-binding. {ECO:0000250}.
FT   REGION      377    379       Molybdopterin-binding. {ECO:0000250}.
FT   REGION      402    538       Homodimerization. {ECO:0000250}.
FT   METAL       118    118       Iron (heme axial ligand).
FT   METAL       143    143       Iron (heme axial ligand).
FT   METAL       264    264       Molybdenum. {ECO:0000250}.
FT   BINDING     145    145       Heme b. {ECO:0000269|PubMed:12832761}.
FT   BINDING     147    147       Heme b. {ECO:0000269|PubMed:12832761}.
FT   BINDING     322    322       Molybdopterin. {ECO:0000250}.
FT   BINDING     361    361       Molybdopterin. {ECO:0000250}.
FT   BINDING     366    366       Molybdopterin. {ECO:0000250}.
FT   MOD_RES     123    123       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VARIANT     217    217       R -> Q (in ISOD; 2% of activity;
FT                                dbSNP:rs121908007).
FT                                {ECO:0000269|PubMed:12368985,
FT                                ECO:0000269|PubMed:9428520,
FT                                ECO:0000269|PubMed:9600976}.
FT                                /FTId=VAR_002200.
FT   VARIANT     258    258       I -> L (in ISOD).
FT                                {ECO:0000269|PubMed:12112661}.
FT                                /FTId=VAR_015724.
FT   VARIANT     265    265       A -> D (in ISOD; dbSNP:rs121908008).
FT                                {ECO:0000269|PubMed:10519592,
FT                                ECO:0000269|PubMed:9428520}.
FT                                /FTId=VAR_002201.
FT   VARIANT     268    268       R -> Q (in ISOD).
FT                                {ECO:0000269|PubMed:12112661}.
FT                                /FTId=VAR_015725.
FT   VARIANT     362    362       G -> S (in ISOD; dbSNP:rs757559168).
FT                                {ECO:0000269|PubMed:12112661}.
FT                                /FTId=VAR_015726.
FT   VARIANT     366    366       R -> H (in ISOD; dbSNP:rs776690106).
FT                                {ECO:0000269|PubMed:12112661}.
FT                                /FTId=VAR_015727.
FT   VARIANT     379    379       K -> R (in ISOD; dbSNP:rs777114729).
FT                                {ECO:0000269|PubMed:12112661}.
FT                                /FTId=VAR_015728.
FT   VARIANT     396    396       Q -> R (in ISOD).
FT                                {ECO:0000269|PubMed:12112661}.
FT                                /FTId=VAR_015729.
FT   VARIANT     427    427       S -> Y (in ISOD).
FT                                {ECO:0000269|PubMed:10519592,
FT                                ECO:0000269|PubMed:9428520}.
FT                                /FTId=VAR_002202.
FT   VARIANT     450    450       W -> R (in ISOD).
FT                                {ECO:0000269|PubMed:12112661}.
FT                                /FTId=VAR_015730.
FT   VARIANT     530    530       G -> D (in ISOD; dbSNP:rs121908009).
FT                                {ECO:0000269|PubMed:9428520}.
FT                                /FTId=VAR_002203.
FT   TURN         96     98       {ECO:0000244|PDB:1MJ4}.
FT   STRAND       99    104       {ECO:0000244|PDB:1MJ4}.
FT   STRAND      107    110       {ECO:0000244|PDB:1MJ4}.
FT   TURN        112    114       {ECO:0000244|PDB:1MJ4}.
FT   HELIX       115    117       {ECO:0000244|PDB:1MJ4}.
FT   HELIX       122    126       {ECO:0000244|PDB:1MJ4}.
FT   TURN        127    130       {ECO:0000244|PDB:1MJ4}.
FT   STRAND      131    133       {ECO:0000244|PDB:1MJ4}.
FT   HELIX       134    137       {ECO:0000244|PDB:1MJ4}.
FT   HELIX       141    143       {ECO:0000244|PDB:1MJ4}.
FT   HELIX       146    153       {ECO:0000244|PDB:1MJ4}.
FT   STRAND      156    159       {ECO:0000244|PDB:1MJ4}.
SQ   SEQUENCE   545 AA;  60283 MW;  39B842C55D39E11F CRC64;
     MLLLHRAVVL RLQQACRLKS IPSRICIQAC STNDSFQPQR PSLTFSGDNS STQGWRVMGT
     LLGLGAVLAY QDHRCRAAQE STHIYTKEEV SSHTSPETGI WVTLGSEVFD VTEFVDLHPG
     GPSKLMLAAG GPLEPFWALY AVHNQSHVRE LLAQYKIGEL NPEDKVAPTV ETSDPYADDP
     VRHPALKVNS QRPFNAEPPP ELLTENYITP NPIFFTRNHL PVPNLDPDTY RLHVVGAPGG
     QSLSLSLDDL HNFPRYEITV TLQCAGNRRS EMTQVKEVKG LEWRTGAIST ARWAGARLCD
     VLAQAGHQLC ETEAHVCFEG LDSDPTGTAY GASIPLARAM DPEAEVLLAY EMNGQPLPRD
     HGFPVRVVVP GVVGARHVKW LGRVSVQPEE SYSHWQRRDY KGFSPSVDWE TVDFDSAPSI
     QELPVQSAIT EPRDGETVES GEVTIKGYAW SGGGRAVIRV DVSLDGGLTW QVAKLDGEEQ
     RPRKAWAWRL WQLKAPVPAG QKELNIVCKA VDDGYNVQPD TVAPIWNLRG VLSNAWHRVH
     VYVSP
//
